Total Funding
48
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
91622
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Acquired by 
Boston Scientific
Guangqiang Jiang: Co-Founder & Chief Technology Officer- Rinda Sama: Vice President, Operations and QualityPast Role: Vessix Vascular, Director of Operations and Quality
About the Company
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
